about
New Features about Tau Function and DysfunctionAlternative neural circuitry that might be impaired in the development of Alzheimer diseaseTau StructuresVariations in brain DNASimilarities and differences between exome sequences found in a variety of tissues from the same individualAdditional mechanisms conferring genetic susceptibility to Alzheimer's diseaseTau deficiency leads to the upregulation of BAF-57, a protein involved in neuron-specific gene repressionFunction of tau protein in adult newborn neuronsDNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease.GSK3β Overexpression in Dentate Gyrus Neural Precursor Cells Expands the Progenitor Pool and Enhances Memory Skills.Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicityUltrastructural localization of fructose-1,6-bisphosphatase in mouse brain.Different susceptibility to neurodegeneration of dorsal and ventral hippocampal dentate gyrus: a study with transgenic mice overexpressing GSK3β.Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA.Peripherally triggered and GSK-3β-driven brain inflammation differentially skew adult hippocampal neurogenesis, behavioral pattern separation and microglial activation in response to ibuprofen.Thermodynamics of the interaction between Alzheimer's disease related tau protein and DNADistinct X-chromosome SNVs from some sporadic AD samplesThe Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and PathologyPARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesTau pathology-mediated presynaptic dysfunctionTau antagonizes end-binding protein tracking at microtubule ends through a phosphorylation-dependent mechanism.Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns."Tau oligomers," what we know and what we don't know.The role of GSK3 in Alzheimer disease.GSK3 inhibitors and disease.GSK3: a possible link between beta amyloid peptide and tau protein.Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer's disease.GSK-3β Overexpression Alters the Dendritic Spines of Developmentally Generated Granule Neurons in the Mouse Hippocampal Dentate GyrusThe role of extracellular Tau in the spreading of neurofibrillary pathology.Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.The tau code.Tau phosphorylation in hippocampus results in toxic gain-of-function.Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease.Neuronal models for studying tau pathology.Overcoming cell death and tau phosphorylation mediated by PI3K-inhibition: a cell assay to measure neuroprotection.GSK3 and tau: two convergence points in Alzheimer's disease.Looking for novel functions of tau.New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease.Regulation of EB1/3 proteins by classical MAPs in neurons.
P50
Q26750922-2A9CBE0E-5325-4D1D-855D-041C95341574Q27001223-31129B34-132B-4BD7-A172-BB1F1FA61FC8Q28076921-DB99FAC9-9255-448A-854C-35FBC42EEA64Q28383011-5F092E62-5486-43B2-8B68-D041ECBC8D8FQ28389133-DC2973B2-A76F-48E5-A26D-35533396C504Q28391511-E4909973-68CF-40BD-9AA2-07DC2D4695E7Q28586900-7CAFDE73-CE18-4DB3-B75D-8591C9011E45Q28587934-F598BDA5-1741-465E-8BAB-158F3F97B92AQ30009564-94575610-7DF6-4940-B1EB-C9F54AFC74E2Q30359195-89D28614-6117-48CB-8E47-14155CEA7079Q30472712-1D13A311-2FF8-4CD2-80A0-B79F73364335Q33650007-A803F6D6-6B8A-46E7-8332-8608091CA5E9Q34071884-A7A7CE52-897A-41C8-87B0-B398D6ED3756Q34996880-B4509D28-E99E-4992-8CEF-88795E5128ACQ35150206-1805E695-CCAF-4DA6-8E1D-325B3E25BC52Q35225615-48A74180-DE24-4987-AF97-3145C8FAD8CDQ36356882-878B341D-AEA0-4A0B-A489-FAE1DF504D58Q36475393-9E6BECB8-E175-4B9A-BDDA-1D2FEF7B8041Q36551305-9AE050A2-B3C7-4635-A5F7-FA1414940EA5Q36830938-5F591731-C509-4AF1-BDF5-820A85DABB61Q36951523-4F9D1098-5E25-44B1-9DDC-EB2322762799Q37297103-D22BB3D5-BE81-4058-8579-3E3AE1CC86C0Q37347856-DF93E6A6-29DA-4ED5-9FBC-BFCEF1B308C0Q37467443-8C43D369-EE08-4E37-9D55-45A30C2BA4A4Q37499256-740CE350-F94B-484D-A9BA-370780384F2EQ37581896-5C137536-EC84-4D5E-9FD4-04FCCC149962Q37603624-388BF855-10ED-4BBF-92CD-04C8E2B126C6Q37642163-4B4926F8-1DC7-447F-94D2-5B4A8206C6DFQ37692033-478E4D25-1DF8-44EF-8C88-E14672ACF060Q37734856-4F601DEF-CC47-43B0-BB10-FBFD09B9F2B7Q37737294-2003DF14-1DDA-4495-9AE9-83EF8097678BQ37765479-46C2A043-207F-44AD-9566-EF9D34E68B08Q37775656-4C870E41-CBF9-4CA0-998B-8B0389EBDDA0Q37779109-F0B70F22-1B23-48A9-81A9-A3164B271E9FQ37780959-72208098-9E64-4506-AE5C-06A52B409C6AQ37827537-533A0058-C34F-430A-B150-D7A188414B6FQ38019797-19FB06AB-1D52-4C2C-9CCF-D1EC98AE88D1Q38027934-9D2ACA14-BECB-4D1B-82C8-3A32D713CF65Q38149943-A34E551F-7070-4B01-ADB8-E3523AF324A0Q38180931-3E9D8BA2-A1EB-45D9-860D-25CA76601292
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jesus Avila
@ast
Jesus Avila
@en
Jesus Avila
@es
Jesus Avila
@nl
type
label
Jesus Avila
@ast
Jesus Avila
@en
Jesus Avila
@es
Jesus Avila
@nl
prefLabel
Jesus Avila
@ast
Jesus Avila
@en
Jesus Avila
@es
Jesus Avila
@nl
P1053
I-2610-2015
P106
P1153
36047921700
P21
P31
P496
0000-0002-6288-0571